Data / Form D filings / Ceretype Neuromedicine, Inc.
Ceretype Neuromedicine, Inc.: Form D filings
Ceretype Neuromedicine, Inc., a biotechnology company in Cambridge, MA, filed 2 Form D notices with the SEC between 2021 and 2025. The latest, on December 18, 2025, reports $400,000 sold of a $400,000 offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1 Broadway, 14th Floor, Cambridge, MA, 02142
- Phone
- (917) 796-7706
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1884863
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | New notice | $400,000 | $400,000 | 3 | Aug 6, 2024 | sec.gov | |
| Nov 22, 2021 | New notice | $2,500,000 | $1,375,000 | $1,125,000 | 8 | Nov 9, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Silbersweig | Director | |
| Emily Stern | Executive Officer, Director | |
| Richard Lipkin | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Dec 15, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ceretype Neuromedicine, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.